Price
$86.46-15.90%Social Signal Score
Analyst Ratings
41 analysts52-week range
- Last close
- $86.46
- Off 52w high
- -21.8%
- 200-day average
- $87.68
- vs 200-day
- -1.4%
Revenue
$106.10B+137.80%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- J. David Joyner
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Employees
- 259,500
- Beta
- 0.58
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.44
Financials
Revenue
$106.10B+137.8%Net Income
$3.00B+94.5%EBITDA
$5.86B+75.9%Free Cash Flow
$5.65B+64.9%EPS (diluted)
$2.31+61.5%Shares Outstanding (diluted)
1.28B+19.6%Cash & Debt
$13.96BReturn of Capital
$878.00MRevenue by Segment (annual)
$389.16BDividend per Share
$0.67Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $402.07B | $1.77B | $1.40 |
| 2024 | $372.81B | $4.61B | $3.66 |
| 2023 | $357.78B | $8.34B | $6.49 |
| 2022 | $322.47B | $4.31B | $3.29 |
| 2021 | $292.11B | $8.00B | $6.00 |
| 2020 | $268.71B | $7.18B | $5.48 |
| 2019 | $256.78B | $6.63B | $5.10 |
| 2018 | $194.58B | $-594.00M | $-0.57 |
| 2017 | $184.79B | $6.62B | $6.47 |
| 2016 | $177.55B | $5.32B | $4.93 |
| 2015 | $153.29B | $5.24B | $4.66 |
| 2014 | $139.37B | $4.64B | $3.98 |
| 2013 | $126.76B | $4.59B | $3.77 |
| 2012 | $123.12B | $3.86B | $3.05 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CVS's reported EPS growth of -5.8% a year over 13 years.
- EPS in 5 years
- $1.04
- Implied price
- $59.00
- Return from $86.46
- -7.4% a year
To earn 15.0% a year on these assumptions you'd need to buy at $29.33 — -66.1% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 39 | 48 | 57 | 66 | 75 |
|---|---|---|---|---|---|
| -15.8% | -23.2% | -20.0% | -17.2% | -14.7% | -12.5% |
| -10.8% | -18.7% | -15.2% | -12.3% | -9.7% | -7.3% |
| -5.8% | -14.1% | -10.5% | -7.4% | -4.6% | -2.1% |
| -0.8% | -9.6% | -5.7% | -2.4% | 0.5% | 3.1% |
| 4.2% | -5.0% | -1.0% | 2.5% | 5.5% | 8.3% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
97+93.33%Social Signal Score
Mentions (65)
- Newszacks.com·21h ago·Neutral
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report? CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
View source ↗ - Newszacks.com·1d ago·Positive
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
View source ↗ - Newsprnewswire.com·1d ago·Neutral
CVS Health to hold third quarter 2026 earnings conference call WOONSOCKET, R.I., Oct. 5, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, November 4, 2026, at 8:00 a.m.
View source ↗ - Newsfool.com·4d ago·Positive
These 3 Dividend Stocks Yield Less Than 10-Year Treasuries Over 5%. Here's Why They Are Better Buys Anyway. Treasuries pay more today, but these three healthcare dividend payers offer something Treasuries can't: growth in both the payout and the stock.
View source ↗ - News (RSS)investing·4d ago·Neutral
Cardinal Health rises on extended CVS distribution deal
View source ↗ - News (RSS)seekingalpha·4d ago·Positive
CVS Group plc (CVSGF) Q4 2026 Earnings Call Transcript
View source ↗ - Newsprnewswire.com·5d ago·Neutral
CVS Health declares quarterly dividend WOONSOCKET, R.I., Sept. 30, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
View source ↗ - Newszacks.com·7d ago·Neutral
CVS Health (CVS) Falls More Steeply Than Broader Market: What Investors Need to Know The latest trading day saw CVS Health (CVS) settling at $87.85, representing a -1.44% change from its previous close.
View source ↗ - News (RSS)seekingalpha·10d ago·Neutral
CVS Health Stock Still Looks Good Even If Health Cost Woes Materialize
View source ↗ - Newsseekingalpha.com·10d ago·Positive
CVS Health Stock Still Looks Good Even If Health Cost Woes Materialize CVS Health Corporation stock remains fairly attractive as a growing industry leader, currently rated a soft Buy due to improved profitability and relative valuation. Recent results show revenue up 6.7% year-over-year to $206.5B and net income more than doubling, driven by segment-level operational improvements. CVS's Health Care Benefits segment reversed prior profitability declines, aided by strategic exits and a lower medic…
View source ↗ - News (RSS)thestreet·10d ago·Negative
Walmart, CVS, and Family Dollar face retail theft scam Forget shoplifting, this crime is even more dangerous for shoppers.
View source ↗ - Newszacks.com·10d ago·Neutral
Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It? The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
View source ↗ - News (Marketaux)seekingalpha.com·11d ago·Positive
CVS Health shares fell for eight consecutive sessions (NYSE:CVS) CVS Health (CVS) share[+218 characters]
View source ↗ - News (RSS)seekingalpha·11d ago·Neutral
CVS Group plc 2026 Q4 - Results - Earnings Call Presentation
View source ↗ - News (RSS)seekingalpha·11d ago·Positive
CVS Group plc (CVSGF) Q4 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·11d ago·Positive
Here's Why CVS Health (CVS) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newszacks.com·12d ago·Neutral
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - News (RSS)independent·12d ago·Neutral
Vet group CVS says portrayal of industry ‘disappointing’ amid reforms The company also announced its first acquisition in the UK days after the conclusion of the Competition and Markets Authority probe.
View source ↗ - Newsprnewswire.com·12d ago·Neutral
As measles cases rise in Tennessee, CVS Health® reminds residents that vaccines are available statewide /PRNewswire/ -- Following the Tennessee Department of Health's recent confirmation of nine measles cases in the state, CVS Health (NYSE: CVS) is reminding
View source ↗ - Newsbenzinga.com·13d ago·Neutral
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
View source ↗ - Newszacks.com·13d ago·Positive
Why CVS Health (CVS) is a Top Growth Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
View source ↗ - Newszacks.com·14d ago·Neutral
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors CVS Health (CVS) concluded the recent trading session at $87.6, signifying a -1.4% move from its prior day's close.
View source ↗ - Newszacks.com·14d ago·Neutral
Here's What Might Affect CVS Health's 2026 Financial Outlook CVS raises its 2026 revenue and earnings outlook, but reimbursement pressure, macro headwinds and soft front-store demand could weigh on results.
View source ↗ - News (RSS)thestreet·17d ago·Negative
A drugmaker is gaining from the side effects of weight-loss drugs The consumer health company's GLP-1 shelf strategy at CVS is paying off, and bigger retailers could follow.
View source ↗ - News (RSS)thestreet·17d ago·Negative
CVS division completes Chapter 11 bankruptcy liquidation A piece of the company is winding down its operations under CVS Health.
View source ↗ - Newszacks.com·20d ago·Neutral
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights CVS Health (CVS) concluded the recent trading session at $94.43, signifying a -1.17% move from its prior day's close.
View source ↗ - News (RSS)yahoo·21d ago·Neutral
CVS Stock Returned $24B In Cash: Why Did It Still Lag The Market?
View source ↗ - News (RSS)fool·21d ago·Positive
Should You Buy CVS Stock on the Dip? CVS Health is looking more attractive -- and it sports an appealing dividend, too, recently yielding 2.8%.
View source ↗ - News (RSS)zerohedge·22d ago·Positive
… corporations and foundations that have business before the California state government, creating the appearance of a pay-to-play arrangement in which companies like CVS, Zoox, and a Blue Shield-linked foundation gain access to, or favor with, a governor whose regulatory decisions directly affect their bottom lines. Newsom also sought money from the left-leaning dark-money outfit New Venture Fund and crypto billionaire Chris Larsen. Foundations tied to philanthropists Susie Tompkins Buell and Li…
View source ↗ - News (RSS)forbes·22d ago·Neutral
Is The Health Insurer Rebound Complete? Some Seem To Think So An increasing number of industry analysts say costs are under control for the likes of CVS Health, Centene, Cigna, Elevance Health, Humana, UnitedHealth Group and others.
View source ↗ - News (RSS)yahoo·23d ago·Positive
Walgreens retreats as CVS quietly takes over suburban pharmacies
View source ↗ - News (RSS)thestreet·23d ago·Positive
Walgreens retreats as CVS quietly takes over suburban pharmacies CVS is picking up the overflow as Walgreens closes 1,200 stores and goes private.
View source ↗ - News (RSS)zerohedge·23d ago·Negative
… a mother taking Tylenol - also known as acetaminophen or paracetamol - during pregnancy, according to researchers in Denmark. Tylenol and acetaminophen tablets in a CVS store, in this file photo. Ronaldo Schemidt/AFP via Getty Images On average, infant girls exposed to the pain relief drug in the womb had smaller ovaries; fewer ovarian follicles, which are the structures that contain immature eggs; smaller wombs; and lower levels of reproductive hormones, according to the findings of the study …
View source ↗ - News (RSS)fortune·25d ago·Neutral
Broken bridge and commuter fury combine to defeat Rhode Island’s governor — at the hands of the CVS exec he vanquished 4 years ago Helena Foulkes defeated Rhode Island Gov. Dan McKee in the state’s Democratic primary Wednesday, making him the first governor in any U.S. state to lose a party primary since 2018. McKee’s defeat ends his bid for a second full term and marks the first time in more than 30 years that a sitting Rhode Island […]
View source ↗ - Newsseekingalpha.com·26d ago·Positive
CVS Health: Buy The Pullback Before Earnings Power Ramps Up CVS Health trades at a discounted 12x forward P/E versus peers, despite robust business momentum and integrated healthcare assets. Q2 2026 saw 7% YoY revenue growth to $106B and 35% adjusted operating income growth, signaling a turnaround in earnings power. Aetna margin restoration, specialty pharmacy growth, and GLP-1 expansion offset risks from elevated medical costs and regulatory headwinds.
View source ↗ - Newsmarketbeat.com·26d ago·Neutral
CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom CVS Health NYSE: CVS executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds.
View source ↗ - Newszacks.com·26d ago·Positive
Here's Why CVS Health (CVS) is a Strong Momentum Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newszacks.com·27d ago·Neutral
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
View source ↗ - News (RSS)fool·27d ago·Positive
Wall Street Loves CVS Health Stock Right Now. Should You? The stock is down about 13% from its 52-week high.
View source ↗ - Newsprnewswire.com·27d ago·Negative
CVS Health marks 20 years of free community health screening program as new survey reveals many U.S. adults still face barriers to preventive health screenings WOONSOCKET, R.I., Sept. 9, 2026 /PRNewswire/ -- New survey findings commissioned by CVS Health® (NYSE: CVS) reveal that many Americans face persistent barriers accessing preventive health screenings.
View source ↗ - Newsfool.com·27d ago·Positive
Wall Street Loves CVS Health Stock Right Now. Should You? CVS Health has significantly improved its business since last year. The company is performing well financially as a result.
View source ↗ - News (RSS)yahoo·30d ago·Positive
Jim Cramer Says “Own It, Don’t Trade It” as CVS Health Gains Momentum
View source ↗ - Newsprnewswire.com·32d ago·Neutral
Updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic across the U.S. Appointments can be scheduled through the CVS Health app or CVS.com and walk-ins are accepted WOONSOCKET, R.I., Sept. 3, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that updated 2026-2027 COVID-19 vaccines are now available at CVS Pharmacy® and MinuteClinic® locations for patients at no-cost with most insurance plans.
View source ↗ - Newszacks.com·34d ago·Positive
Here's How CVS' Improving Balance Sheet Supports Deleveraging CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.
View source ↗ - News (RSS)yahoo·34d ago·Neutral
Why CVS Stock Rallied Tuesday Morning
View source ↗ - Newsfool.com·37d ago·Positive
Wall Street Isn't Giving Up on CVS Health -- and Its Valuation Looks Stronger Than Investors Think CVS reported triple-digit earnings growth in the second quarter. The company also upgraded its yearly guidance.
View source ↗ - Newszacks.com·39d ago·Positive
How CVS' Pharmacy & Consumer Wellness Is Positioned for H2 2026 CVS Health carries strong pharmacy momentum into H2 2026, with rising prescription volume, Rite Aid gains and higher profit.
View source ↗ - Newsprnewswire.com·40d ago·Neutral
CVS Pharmacy® and MinuteClinic® now offering updated flu vaccines nationwide CVS Health survey finds more than 60 percent of consumers say they are likely to get a flu shot this season. Expanded testing and treatment services help make CVS Pharmacy a convenient destination for seasonal care.
View source ↗ - News (RSS)seekingalpha·43d ago·Positive
CVS Health: Discounted, Vertically Integrated Healthcare Winner - Richer Returns Ahead
View source ↗ - Newsseekingalpha.com·43d ago·Neutral
CVS Health: Discounted, Vertically Integrated Healthcare Winner - Richer Returns Ahead The vertically integrated healthcare model across insurance, PBM, pharmacy, and clinical care capabilities underscores CVS Health's multi-year margin recovery prospects. This strategy has driven the better patient outcomes, superior membership retention, moderating medical benefit ratios, and robust revenue/margin expansion. Recent selloff has unlocked a cheaper P/E of 11.78x, along with the dual return prospe…
View source ↗ - News (Marketaux)finance.yahoo.com·44d ago·Neutral
CVS Health Stock Is Beating the Market in 2026. Here's Why Wall Street Thinks It Can Soar Another 22%. One of the hotter stocks in big healthca[+311 characters]
View source ↗ - Newsfool.com·44d ago·Positive
CVS Health Stock Is Beating the Market in 2026. Here's Why Wall Street Thinks It Can Soar Another 22%. It has added considerably to the company's fundamentals. Zooming out, CVS has crushed analyst profitability estimates lately.
View source ↗ - News (RSS)zerohedge·45d ago·Positive
… and that her husband is the killer. Even though numerous pieces of evidence including surveillance footage and cell phone tracking shows Clancy's husband at a local CVS pharmacy at the time of the murder, these women have read hundreds of true crime novels and think they are better investigators than the authorities involved. Some commenters note that a similar mob of female detectives has been spreading endless conspiracy theories about Tyler Robinson and the murder of Charlie Kirk, even thoug…
View source ↗ - PodcastCompound And Friends·48d ago·Neutral
…re Ventures and he's just where that, what's the difference? He's a Twitter addict. I think he checks his Twitter every 10 minutes and he does, he's famous for these CVS receipt length tweets and he's, to his credit, he's in the mix, like he doesn't hide from people, he says, what he thinks, people criticize him, he comes back. I don't do that shit, I don't know why, he does that, but I respect it, but anyway, so he announced this thing, Persian Square Ventures, I think it's interesting, nobody …
View source ↗ - News (RSS)zerohedge·48d ago·Neutral
…re stealing things like, you know, soap. And that means if you're stealing those things, you need them. And we are choosing to protect billion-dollar companies, like CVS and Walgreens, over the people who are struggling to get by," Gallagher said, according to the New York Post. "So I would say that the true crime is that there is such incredible wealth disparity in this city that there are people who can be thrown in jail simply for having a biological need." Gallagher went on to tout her soft-…
View source ↗ - Newsprnewswire.com·49d ago·Neutral
CVS Health Announces Board Changes Teresa Heitsenrether to join the Board, bringing more than forty years of operating experience across data, analytics and technology at one of the world's largest financial institutions Larry Robbins to depart the Board after two years at CVS Health WOONSOCKET, R.I., Aug. 17, 2026 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the appointment of Teresa Heitsenrether to its Board of Directors and departure of Larry Robbins from its Board.
View source ↗ - Newszacks.com·49d ago·Positive
Is CVS Stock a Buy as Earnings Improve but Key Risks Remain Elevated? CVS Health enters the second half of 2026 with stronger earnings and Aetna gains, but medical costs and Caremark risks cloud the recovery.
View source ↗ - Newszacks.com·49d ago·Positive
CVS' Q2 EPS Gains From Improved Health Care Benefits Profitability CVS Health's Q2 EPS jumps more than 40% as Health Care Benefits profitability improves, prompting a major boost to its 2026 AOI outlook.
View source ↗ - 4chan /biz/biz·51d ago·Neutral
>CVS charges 500% more than what Walmart or Target do for Ibuprofen
View source ↗ - Newszacks.com·52d ago·Positive
Can CVS Sustain Its 2026 Recovery After Raising Earnings Guidance? CVS Health is rebuilding momentum as Aetna drives stronger profits and higher 2026 guidance, but medical costs and PBM changes could test the recovery.
View source ↗ - Newszacks.com·52d ago·Neutral
How CVS Is Building on Its Consumer-Health Care Technology Push CVS Health advances its $20 billion technology push with AI tools, Health100 and automation aimed at simplifying care and improving engagement.
View source ↗ - News (RSS)fool·54d ago·Positive
CVS Health (CVS) Q2 2026 Earnings Call Transcript Adjusted EPS surged 42.5% on margin recovery across all operating segments.
View source ↗ - Newszacks.com·55d ago·Positive
Here's Why CVS Health (CVS) is a Strong Growth Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newsseekingalpha.com·57d ago·Neutral
CVS Health: I Wanted A Beat And Raise, I Got It, And I'm Still At 'Hold' CVS Health Corporation's strong Q2 results delivered revenue and earnings beats while management raised operating cash flow guidance to $11.5 billion. Aetna turnaround and improved medical benefit ratios boosted first half cash generation, helping drive recent stock gains. Management anticipates higher second half medical costs alongside 2027 headwinds from 340B pricing and pharmacy drug mix shifts.
View source ↗ - News (RSS)cnbc·61d ago·Neutral
CVS blows past estimates, hikes guidance as insurance unit continues to improve CVS also announced a new collaboration with Eli Lilly that will make Zepbound and Foundayo accessible to eligible patients on the CVS Health app.
View source ↗
Earnings
Wed, Nov 4(in 4 weeks)
Consensus estimate $1.64 per share
Typical surprise +24.0% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$2.58 vs $1.87beat
- Wed, May 6$2.57 vs $2.21beat
- Tue, Feb 10$1.09 vs $1.00beat
- Wed, Oct 29$1.60 vs $1.37beat
- Thu, Jul 31$1.81 vs $1.46beat
- Thu, May 1$2.25 vs $1.70beat
Estimates and results for CVS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CVS officers and directors.
- Bought
- $106k
- Sold
- $346.3m
5 trades
10 trades
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
- Robbins Larrysold
85 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Thomas Hawley Tubervillesenate · AL · disclosed Aug 5, 2026 (709d later)Sell$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2026 (36d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 11, 2026 (41d later)Buy$1,001 - $15,000
- Dwight Evanshouse · PA03 · disclosed May 15, 2026 (175d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed May 13, 2026 (30d later)Buy$1,001 - $15,000
- John Boozmansenate · AR · disclosed Feb 15, 2026 (17d later)Buy$1,001 - $15,000
- Michael T. McCaulhouse · TX10 · disclosed Feb 12, 2026 (30d later)Sell$15,001 - $50,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (12d later)Sell$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (445d later)Buy$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (398d later)Sell$1,001 - $15,000
- Dwight Evanshouse · PA03 · disclosed Dec 22, 2025 (31d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (24d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Nov 24, 2025 (25d later)Buy$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Oct 10, 2025 (17d later)Sell$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Sep 12, 2025 (318d later)Buy$1,001 - $15,000
- Adam Smithhouse · WA09 · disclosed Aug 8, 2025 (0d later)Sell$1,001 - $15,000
- Jefferson Shrevehouse · IN06 · disclosed Jun 23, 2025 (42d later)Sell$15,001 - $50,000
- Robert P. Bresnahanhouse · PA08 · disclosed Jun 2, 2025 (18d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
